In the last few years, there have been many changes to the flu vaccine market in terms of providers, cohorts and types of vaccine.
The 2023-24 season will see further changes as MASTA will not be supplying flu vaccines to the GP market next year. This will leave only three providers: CSL Seqirus, Viatris (formerly Mylan) and Sanofi.
Our role in this upcoming flu season has been liaising with the providers to collate vaccine information and the terms offered by each provider such as sale or return, reserves, and early delivery. We are then able to share this information with our members, so you feel confident placing your orders, and knowing you have secured the delivery dates to suit your practice.
Sanofi have decided not to share information with us for the 2023-24 season but we have collated the information from CSL Seqirus and Viatris. You’ll need to login to view all the details on the Flu Vaccines page.